arrow
Z

Zhewei Kang

Peking University
H指数:8
被引数:168

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Distinct contributions of schizophrenia and neurotransmitter pathway genetic liability to neurocognition and antipsychotic efficacy in drug-naïve first-episode schizophrenia

精神分裂症和神经递质通路遗传易感性对药物初治首发精神分裂症患者神经认知及抗精神病药效的不同贡献

2026-06-150
PRE
Identifying genetic contributions of 6q21 loci and PPAR pathway to antipsychotic-induced metabolic syndrome: a Sex-Stratified Multi-Omics study

鉴定6q21位点与PPAR通路对抗精神病药物诱导代谢综合征的遗传贡献:一项按性别分层的多组学研究

2026-03-010
PRE
Efficacy and Tolerability of Seven Antipsychotic Drugs in Acutely Ill Patients With Schizophrenia: A Randomized, Multicenter, Assessor-Blinded Trial

七种抗精神病药物在急性期精神分裂症患者中的疗效和耐受性:一项随机、多中心、评估者盲法的试验

2026-02-018
PRE
Nkapl deletion drives cognitive deficits through mPFC interneuron dysfunction in a mouse model of schizophrenia

Nkapl基因缺失通过mPFC中间神经元功能障碍驱动精神分裂症小鼠模型中的认知缺陷

2025-10-010
PRE
Clarifying Fundamental Role of Symbol Coding in Cognitive Networks in Schizophrenia and Healthy Controls Leveraging Gaussian Graphical Models and Bayesian Networks

利用高斯图形模型和贝叶斯网络阐明符号编码在精神分裂症和健康控制中的认知网络中的基本作用

2025-03-010
PRE
Dose adjustment of paroxetine based on CYP2D6 activity score inferred metabolizer status in Chinese Han patients with depressive or anxiety disorders: a prospective study and cross-ethnic meta-analysis
2024-06-010
OAAI